P. Aschoff

发表

Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.

C. Claussen, H. Schlemmer, C. Garbe, 2007, European journal of cancer.

Histological verification of 11C‐choline‐positron emission/computed tomography‐positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer

Roland Bares, Philip Aschoff, Arnulf Stenzl, 2008, BJU international.

Value of contrast-enhanced multiphase CT in combined PET/CT protocols for oncological imaging.

C. Claussen, R. Bares, S. Eschmann, 2007, The British journal of radiology.

Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma: Initial Results

I. Zuna, S. Eschmann, C. Plathow, 2008, Investigative radiology.

Single and dual energy attenuation correction in PET/CT in the presence of iodine based contrast agents.

Bernd J Pichler, Jürgen Kupferschläger, Niklas S Rehfeld, 2008, Medical physics.

Presumed Tuberculosis-induced Retinal Vasculitis, Diagnosed with Positron Emission Tomography (18F-FDG-PET/CT), Aspiration Biopsy, and Culture

J. Hetzel, M. Zierhut, C. Pfannenberg, 2010, Ocular immunology and inflammation.

FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies.

M. Reimold, M. Werner, C. Pfannenberg, 2011, The British journal of radiology.

18F-FDG-PET/CT to Select Patients with Peritoneal Carcinomatosis for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

C. Claussen, K. Nieselt, A. Königsrainer, 2009, Annals of Surgical Oncology.

Comparison of 11C-choline-PET/CT and whole body-MRI for staging of prostate cancer

C. Claussen, H. Schlemmer, A. Rieger, 2006, Nuklearmedizin.

[Cost considerations for whole-body MRI and PET/CT as part of oncologic staging].

C. Claussen, H. Schlemmer, S. Eschmann, 2008, Der Radiologe.

Peritoneal carcinomatosis: comparison of dynamic contrast-enhanced magnetic resonance imaging with surgical and histopathologic findings

C. Claussen, M. Fenchel, N. Schwenzer, 2012, Abdominal Radiology.

Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI

C. Claussen, N. Schwenzer, U. Kramer, 2013, Abdominal Imaging.

Selektion zur Peritonektomie mit hyperthermer intraoperativer Chemotherapie (HIPEC) bei Peritonealkarzinose

A. Königsrainer, J. Hartmann, C. Pfannenberg, 2008, Zentralblatt für Chirurgie.

Integrated FDG-PET/CT for detection, therapy monitoring and follow-up of granulocytic sarcoma

M. Werner, C. Pfannenberg, P. Aschoff, 2009, Nuklearmedizin.

Case Reports: Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping with Correlation to PET/CT Results

M. Lichy, C. Pfannenberg, P. Aschoff, 2009 .

PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?

C. Claussen, L. Kanz, H. Dittmann, 2010, Journal of Nuclear Medicine.

Is There Any Additional Benefit of Contrast-Enhanced CT as Part of Routine PET/CT Protocols for the Differentiation of Suspicious Incidental Gastrointestinal 2-Deoxy-18F-FDG Uptake?

C. Claussen, C. Schraml, M. Reimold, 2013, Korean journal of radiology.

Correlation of preoperative magnetic resonance imaging of peritoneal carcinomatosis and clinical outcome after peritonectomy and HIPEC after 3 years of follow-up: preliminary results

C. Claussen, N. Schwenzer, B. Klumpp, 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

18F-FDG PET/CT for the diagnosis of sarcoidosis in a patient with bilateral inflammatory involvement of the parotid and lacrimal glands (panda sign) and bilateral hilar and mediastinal lymphadenopathy (lambda sign)

M. Werner, C. Pfannenberg, P. Aschoff, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[18F]fluoro-ethylcholine-PET Plus 4D-CT (FEC-PET-CT): A Break-Through Tool to Localize the “Negative” Parathyroid Adenoma. One Year Follow Up Results Involving 170 Patients

G. Reischl, P. Aschoff, A. Zielke, 2021, Journal of clinical medicine.

[Vasculo-Behcet's disease: imaging findings].

P. Aschoff, I. Kötter, M. Horger, 2007, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Multiphase contrast-enhanced CT with highly concentrated contrast agent can be used for PET attenuation correction in integrated PET/CT imaging

C. Claussen, T. Beyer, M. Lichy, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.

Thomas Beyer, Magnus Klein, Roland Bares, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancer

Roland Bares, Philip Aschoff, C. Claussen, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Tumor Detection by Diffusion-Weighted MRI and ADC-Mapping—Initial Clinical Experiences in Comparison to PET-CT

C. Claussen, H. Schlemmer, B. Kiefer, 2007, Investigative radiology.

Nachweis ossärer Metastasen des Prostatakarzinoms – Vergleich der Leistungsfähigkeit der Ganzkörper-MRT und der Skelettszintigrafie

C. Claussen, H. Schlemmer, C. Claussen, 2008, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Staging of neuroendocrine tumours: comparison of [68Ga]DOTATOC multiphase PET/CT and whole-body MRI

C. Claussen, N. Schwenzer, C. Schraml, 2013, Cancer imaging : the official publication of the International Cancer Imaging Society.

MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration

Bernhard Schölkopf, Florian Steinke, Jason Farquhar, 2008, Journal of Nuclear Medicine.

Visualisation of a somatostatin receptor-expressing tumour with 67Ga-DOTATOC SPECT

F. Rösch, K. Zhernosekov, P. Aschoff, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Positron Emission Tomography/Computed Tomography and Whole-Body Magnetic Resonance Imaging in Staging of Advanced Nonsmall Cell Lung Cancer—Initial Results

C. Claussen, H. Schlemmer, S. Eschmann, 2008, Investigative radiology.

[The integrated PET/CT: technological advance in diagnostics of head and neck recurrencies and CUP?].

P. Aschoff, H. Bihl, K. Schneider, 2006, Laryngo- rhino- otologie.

PET/CT with 18F-FLT: Does It Improve the Therapeutic Management of Metastatic Germ Cell Tumors?

C. Claussen, L. Kanz, H. Dittmann, 2010, Journal of Nuclear Medicine.

MRI-Based Attenuation Correction for PET/MRI: A Novel Approach Combining Pattern Recognition and Atlas Registration

M. Brady, F. Steinke, J. Farquhar, 2008, Journal of Nuclear Medicine.